FDA Drug Shortages — Page 9
Browse FDA drug shortages by generic name, company, and status. RegDataLab tracks 1,660 drug shortages from official FDA sources, updated on an ongoing basis.
| Drug shortages | Details |
|---|---|
| Streptozocin Powder, For Solution | Current — ESTEVE PHARMACEUTICALS, S.A. |
| Doxercalciferol Injection | To Be Discontinued — Sanofi-Aventis U.S. LLC |
| Etomidate Injection | Current — Caplin Steriles, Ltd. |
| Scopolamine Transdermal System | To Be Discontinued — Padagis US LLC |
| Montelukast Sodium Tablet, Chewable | To Be Discontinued — Organon |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Current — Granules Pharmaceuticals Inc. |
| Tafamidis Meglumine Capsule | To Be Discontinued — Pfizer Inc. |
| Amino Acid Injection | Current — Baxter Healthcare |
| Lisdexamfetamine Dimesylate Capsule | Current — Apotex Corp. |
| Dexmedetomidine Hydrochloride Injection | Current — Baxter Healthcare |
| Liraglutide Injection | Current — Novo Nordisk, Inc. |
| Methylphenidate Hydrochloride Tablet, Extended Release | Current — Trigen Laboratories, LLC |
| Bumetanide Injection | Current — MSN Laboratories Private Limited |
| Dextrose Monohydrate 70% Injection | Current — B. Braun Medical Inc. |
| Pindolol Tablet | To Be Discontinued — Sun Pharmaceutical Industries, Inc. |
| Naltrexone Hydrochloride Tablet | Resolved — SpecGx LLC |
| Omeprazole Delayed Release Capsule | To Be Discontinued — Sandoz Inc. |
| Quinapril/Hydrochlorothiazide Tablet | Current — Chartwell Molecular Holdings LLC |
| Oxycodone Hydrochloride Oral Solution | To Be Discontinued — Hikma Pharmaceuticals USA, Inc. |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Current — Elite Laboratories, Inc. |
| Clonazepam Tablet | Current — Rubicon Research Private Limited |
| Bupivacaine Hydrochloride Injection | Current — Fresenius Kabi USA, LLC |
| Naltrexone Hydrochloride Tablet | Resolved — Accord Healthcare Inc. |
| Dextrose Monohydrate 10% Injection | Current — Baxter Healthcare |
| Maraviroc Solution | To Be Discontinued — ViiV Healthcare Company |
| Liraglutide Injection | Current — Meitheal Pharmaceuticals, Inc. |
| Bumetanide Injection | Current — Fresenius Kabi USA, LLC |
| Atropine Sulfate Injection | Current — American Regent, Inc. |
| Dopamine Hydrochloride Injection | Current — Hikma Pharmaceuticals USA, Inc. |
| Rifampin Injection | Current — Mylan Institutional, a Viatris Company |
| Amantadine Hydrochloride Capsule | To Be Discontinued — Upsher-Smith Laboratories, LLC |
| Methylphenidate Hydrochloride Tablet, Extended Release | Current — Teva Pharmaceuticals USA, Inc. |
| Furosemide Injection | Current — Hospira, Inc., a Pfizer Company |
| Frovatriptan Succinate Tablet | To Be Discontinued — Endo Pharmaceuticals, Inc. |
| Dextrose Monohydrate 10% Injection | Current — Otsuka ICU Medical LLC |
| Sterile Water Irrigant | Current — Baxter Healthcare |
| Fentanyl Citrate Injection | Current — Hospira, Inc., a Pfizer Company |
| Liraglutide Injection | Current — Meitheal Pharmaceuticals, Inc. |
| Amino Acid Injection | Current — Otsuka ICU Medical LLC |
| Methylprednisolone Acetate Injection | Current — Pfizer Inc. |
| Potassium Chloride Tablet, Extended Release | To Be Discontinued — Upsher-Smith Laboratories, LLC |
| Desipramine Hydrochloride Tablet | To Be Discontinued — Avet Pharmaceuticals, Inc. |
| Amino Acid Injection | Current — Otsuka ICU Medical LLC |
| Dexmedetomidine Hydrochloride Injection | Current — Accord Healthcare Inc. |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Current — Hospira, Inc., a Pfizer Company |
| Rifampin Injection | Current — Fresenius Kabi USA, LLC |
| Dexamethasone Sodium Phosphate Injection | Current — Fresenius Kabi USA, LLC |
| Insulin Degludec Injection | To Be Discontinued — Novo Nordisk, Inc. |
| Lisdexamfetamine Dimesylate Capsule | Current — Lannett Company, Inc. |
| Naltrexone Hydrochloride Tablet | Resolved — Elite Laboratories, Inc. |